A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Genetics

• Publication date

  1993-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8385050PMCID PMC1205401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Mutagenesis of a conserved region of the gene encoding the FLP recombinase of Saccharomyces cerevisiae. A role for arginine 191 in binding and ligation.

  1992cited by this paper
• Cloning and Characterization of an Arabidopsis thaliana Topoisomerase I Gene.

  1992cited by this paper
• The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B.

  1992cited by this paper
• Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in culture.

  1992cited by this paper
• Guide to yeast genetics and molecular biology.

  1991cited by this paper
• Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA.

  1991cited by this paper
• Okadaic acid suppresses calcium regulation of mitosis onset in sea urchin embryos.

  1991cited by this paper
• The S-phase cytotoxicity of camptothecin.

  1991cited by this paper
• New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site.

  1991cited by this paper
• Phenotypic selection and characterization of mutant alleles of a eukaryotic DNA topoisomerase I.

  1990cited by this paper
• Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.

  1990cited by this paper
• A model for tumor cell killing by topoisomerase poisons.

  1990cited by this paper
• Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells.

  1990cited by this paper
• 6 Mechanistic Aspects of Type-I Topoisomerases

  1990cited by this paper
• Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis‐like state in BHK21 cells.

  1990cited by this paper
• Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.

  1989cited by this paper
• A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.

  1989cited by this paper
• Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I.

  1989cited by this paper
• A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase.

  1989cited by this paper
• A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings.

  1989cited by this paper
• The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.

  1989cited by this paper
• Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I.

  1989cited by this paper
• Cloning and sequence analysis of the Saccharomyces cerevisiae RAD9 gene and further evidence that its product is required for cell cycle arrest induced by DNA damage

  1989cited by this paper
• Peptide sequencing and site‐directed mutagenesis identify tyrosine‐319 as the active site tyrosine of Escherichia coli DNA topoisomerase I

  1989cited by this paper
• DNA topoisomerase poisons as antitumor drugs.

  1989cited by this paper
• Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.

  1988cited by this paper
• Deoxyribonucleic acid repair in the yeast Saccharomyces cerevisiae.

  1988cited by this paper
• Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II.

  1988cited by this paper
• The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae.

  1988cited by this paper
• Transcription-dependent DNA supercoiling in yeast DNA topoisomerase mutants.

  1988cited by this paper
• DNA topoisomerase-targeting antitumor drugs can be studied in yeast.

  1988cited by this paper
• Supercoiling of intracellular DNA can occur in eukaryotic cells.

  1988cited by this paper
• Eucaryotic RNA polymerase conditional mutant that rapidly ceases mRNA synthesis

  1987cited by this paper
• 5-Fluoroorotic acid as a selective agent in yeast molecular genetics.

  1987cited by this paper
• Supercoiling of the DNA template during transcription.

  1987cited by this paper
• Plasmid construction by homologous recombination in yeast.

  1987cited by this paper
• A Saccharomyces cerevisiae genomic plasmid bank based on a centromere-containing shuttle vector.

  1987cited by this paper
• Induction of sister chromatid exchanges by inhibitors of topoisomerases

  1986cited by this paper
• Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells.

  1986cited by this paper
• Yeast shuttle and integrative vectors with multiple cloning sites suitable for construction of lacZ fusions.

  1986cited by this paper
• Cloning, characterization, and sequence of the yeast DNA topoisomerase I gene.

  1985cited by this paper
• Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II.

  1985cited by this paper
• Specific Saccharomyces cerevisiae genes are expressed in response to DNA-damaging agents

  1985cited by this paper
• Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

  1985cited by this paper
• Saccharomyces cerevisiae GAL1-GAL10 divergent promoter region: location and function of the upstream activating sequence UASG

  1984cited by this paper
• Identification of Saccharomyces cerevisiae mutants deficient in DNA topoisomerase I activity.

  1984cited by this paper
• Saccharomyces cerevisiae cdc9, a structural gene for yeast DNA ligase which complements Schizosaccharomyces pombe cdc17.

  1983cited by this paper
• Cloning regulated yeast genes from a pool of lacZ fusions.

  1983cited by this paper
• Isolation and characterization of yeast DNA repair genes

  1983cited by this paper
• Tandem gene amplification mediates copper resistance in yeast.

  1982cited by this paper
• High-frequency transformation of yeast: autonomous replication of hybrid DNA molecules.

  1979cited by this paper
• Sterile host yeasts (SHY): a eukaryotic system of biological containment for recombinant DNA experiments.

  1979cited by this paper
• Action of camptothecin on mammalian cells in culture.

  1972cited by this paper
• Effects of cytosine arabinoside, daunomycin, mithramycin, azacytidine, adriamycin, and camptothecin on mammalian cell cycle traverse.

  1972cited by this paper
• Experiments in molecular genetics

  1972cited by this paper
• Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin.

  1971cited by this paper
• Cloning of yeast TOPI, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II

  year unknowncited by this paper

• Genome Instability Induced by Topoisomerase Misfunction

  2024cites this paper
• SUMO: A Swiss Army Knife for Eukaryotic Topoisomerases

  2022cites this paper
• Transcriptome Reprogramming of Symbiodiniaceae Breviolum minutum in Response to Casein Amino Acids Supplementation

  2020cites this paper
• Trapped topoisomerase II initiates formation of de novo duplications via the nonhomologous end-joining pathway in yeast

  2020cites this paper
• Genome-Destabilizing Effects Associated with Top1 Loss or Accumulation of Top1 Cleavage Complexes in Yeast

  2015cites this paper
• Uncovering Factors and Molecular Mechanisms in Transcriptional Regulation in Arabidopsis thaliana

  2012cites this paper
• Chemogenomic profiling of the cellular effects associated with histone H3 acetylation impairment by a quinoline-derived compound.

  2010cites this paper
• The structure and mechanism of the action of type-IB DNA topoisomerases

  2010cites this paper
• A novel approach for organelle-specific DNA damage targeting reveals different susceptibility of mitochondrial DNA to the anticancer drugs camptothecin and topotecan

  2009influential citation
• Mutation of Gly721 Alters DNA Topoisomerase I Active Site Architecture and Sensitivity to Camptothecin*

  2008cites this paper
• Using Yeast Tools to Dissect the Action of Anticancer Drugs: Mechanisms of Enzyme Inhibition and Cell Killing by Agents Targeting DNA Topoisomerases

  2007cites this paper
• Alterations in Linker Flexibility Suppress DNA Topoisomerase I Mutant-induced Cell Lethality*

  2007cites this paper
• The effects of camptothecin on RNA polymerase II transcription: roles of DNA topoisomerase I.

  2007cites this paper
• Recognition of DNA Damage as the Initial Step of Eukaryotic Checkpoint Arrest

  2005cites this paper
• YeastSaccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin

  2004cites this paper
• A Mutation in Human Topoisomerase II α Whose Expression Is Lethal in DNA Repair-deficient Yeast Cells*

  2004cites this paper
• Regions within the N-terminal domain of human topoisomerase I exert important functions during strand rotation and DNA binding.

  2004cites this paper
• Enhanced stimulation of chromosomal translocations by radiomimetic DNA damaging agents and camptothecin in Saccharomyces cerevisiae rad9 checkpoint mutants.

  2004cites this paper
• Enhanced CPT sensitivity of yeast cells and selective relaxation of Ga14 motif-containing DNA by novel Gal4-topoisomerase I fusion proteins.

  2004cites this paper
• Validation of a novel assay for checkpoint responses: characterization of camptothecin derivatives in Saccharomyces cerevisiae.

  2003cites this paper
• Identification of a topoisomerase I mutant, scsA1, as an extragenic suppressor of a mutation in scaA(NBS1), the apparent homolog of human nibrin in Aspergillus nidulans.

  2003cites this paper
• Directed evolution to increase camptothecin sensitivity of human DNA topoisomerase I.

  2001cites this paper
• Residues within the N-terminal Domain of Human Topoisomerase I Play a Direct Role in Relaxation*

  2001cites this paper
• Mechanisms of Resistance to Camptothecins

  2000cites this paper
• Werner's syndrome cell lines are hypersensitive to camptothecin-induced chromosomal damage.

  2000cites this paper
• Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae.

  2000cites this paper
• Recombinogenic Flap Ligation Pathway for Intrinsic Repair of Topoisomerase IB-Induced Double-Strand Breaks

  2000cites this paper
• Mitotic recombination in yeast: elements controlling its incidence

  2000cites this paper
• The Topoisomerase-related Function Gene TRF4 Affects Cellular Sensitivity to the Antitumor Agent Camptothecin*

  1999cites this paper
• Tethering a type IB topoisomerase to a DNA site by enzyme fusion to a heterologous site-selective DNA-binding protein domain.

  1999cites this paper
• Overexpression and purification of DNA topoisomerase I from yeast.

  1999cites this paper
• The topoisomerase I poison camptothecin generates a Chk1‐dependent DNA damage checkpoint signal in fission yeast

  1999influential citation
• Two separate conserved domains of eukaryotic DNA topoisomerase I bind to each other and reconstitute enzymatic activity

  1998cites this paper
• A model for the mechanism of human topoisomerase I.

  1998cites this paper
• Requirement for End-Joining and Checkpoint Functions, but NotRAD52-Mediated Recombination, after EcoRI Endonuclease Cleavage of Saccharomyces cerevisiaeDNA

  1998cites this paper
• Domains of human topoisomerase I and associated functions.

  1998cites this paper
• Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs.

  1998cites this paper
• Intragenic Suppressors of Mutant DNA Topoisomerase I-induced Lethality Diminish Enzyme Binding of DNA*

  1998cites this paper
• Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase I*

  1998cites this paper
• Topoisomerase I-targeting drugs. New developments in cancer pharmacology

  1998cites this paper
• Site-specific ribonuclease activity of eukaryotic DNA topoisomerase I.

  1997cites this paper
• The topoisomerase I gene from Candida albicans.

  1997cites this paper
• A Review of Phenotypes in Saccharomyces cerevisiae

  1997cites this paper
• Alterations in the Catalytic Activity of Yeast DNA Topoisomerase I Result in Cell Cycle Arrest and Cell Death*

  1997cites this paper
• Histidine 265 Is Important for Covalent Catalysis by Vaccinia Topoisomerase and Is Conserved in All Eukaryotic Type I Enzymes*

  1997cites this paper
• Reconstitution of human topoisomerase I by fragment complementation.

  1997cites this paper
• Mechanism of DNA transesterification by vaccinia topoisomerase: catalytic contributions of essential residues Arg-130, Gly-132, Tyr-136 and Lys-167.

  1997cites this paper
• DNA Topoisomerases Regulate R-loop Formation during Transcription of the rrnB Operon in Escherichia coli *

  1997cites this paper
• Identification of a Mid-anaphase Checkpoint in Budding Yeast

  1997cites this paper
• Gene conversion plays the major role in controlling the stability of large tandem repeats in yeast.

  1996cites this paper
• Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair.

  1996cites this paper
• Topoisomerase I involvement in illegitimate recombination in Saccharomyces cerevisiae

  1996cites this paper
• Purification and characterization of human topoisomerase I mutants.

  1996cites this paper
• Topoisomerase I Involvement in Illegitimate Recombination in

  1996cites this paper
• Geneconversion plays themajorroleincontrolling thestability oflarge tandemrepeats inyeast

  1996cites this paper
• DNA topoisomerases.

  1996cites this paper
• Eukaryotic DNA topoisomerases I.

  1995cites this paper
• Cell cycle arrest in response to DNA damage: lessons from yeast.

  1995cites this paper
• SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I.

  1995cites this paper
• A Camptothecin-resistant DNA Topoisomerase I Mutant Exhibits Altered Sensitivities to Other DNA Topoisomerase Poisons (*)

  1995cites this paper
• Mammalian topoisomerase I has base mismatch nicking activity.

  1994cites this paper
• Transcription, topoisomerases and recombination

  1994cites this paper
• Yeast as a genetic model system for studying topoisomerase inhibitors.

  1994cites this paper
• Xi Shu, A Promising Anti-tumor and Anti-viral Tree for the 21st Century

  1994cites this paper
• Appendix. II: Alignment of primary sequences of DNA topoisomerases.

  1994cites this paper
• Mutational analysis of vaccinia DNA topoisomerase defines amino acid residues essential for covalent catalysis.

  1994cites this paper
• Drug resistance mechanisms of topoisomerase I drugs.

  1994cites this paper
• The rRNA-encoding DNA array has an altered structure in topoisomerase I mutants of Saccharomyces cerevisiae.

  1993cites this paper
• RAD9-dependent G1 arrest defines a second checkpoint for damaged DNA in the cell cycle of Saccharomyces cerevisiae.

  1993cites this paper
• DUN1 encodes a protein kinase that controls the DNA damage response in yeast.

  1993cites this paper
• Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.

  1993cites this paper
• Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants.

  1993cites this paper
• Identification and Characterization of the Genes for Two Topoisomerase I-Interacting Proteins from Saccharomyces cerevisiae

  year unknowncites this paper